{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:56:03Z","timestamp":1787068563549,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:00:00Z","timestamp":1553731200000},"content-version":"vor","delay-in-days":239,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["485433\/2012-5"],"award-info":[{"award-number":["485433\/2012-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004916","name":"FAPEAM","doi-asserted-by":"publisher","award":["N.020\/2013"],"award-info":[{"award-number":["N.020\/2013"]}],"id":[{"id":"10.13039\/501100004916","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UFAM"},{"DOI":"10.13039\/501100004586","name":"FAPERJ","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Post-Graduate Program in Pharmaceutical Sciences"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.tiv.2018.03.001","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T03:00:58Z","timestamp":1521687658000},"page":"225-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Anticancer potential of benzothiazolic derivative (E)-2-((2-(benzo[d]thiazol-2-yl)hydrazono)methyl)-4-nitrophenol against melanoma cells"],"prefix":"10.1016","volume":"50","author":[{"given":"Zanair Soares","family":"Vasconcelos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina Lima","family":"Ralph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle Queiroz","family":"Calcagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gleyce","family":"dos Santos Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"do Nascimento Pedrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Pio","family":"Antony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00edlia","family":"de Arruda Cardoso Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza","family":"de Lucas Chazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thatyana Rocha Alves","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Carvalho","family":"Montenegro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marne Carvalho","family":"de Vasconcellos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2018.03.001_bb0005","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(94)90396-4","article-title":"A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay","volume":"170","author":"Ahmed","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.tiv.2018.03.001_bb0010","first-page":"135","article-title":"In vitro antitumor and antiviral activities of new benzothiazole and 1,3,4-oxadiazole-2-thione derivatives","volume":"58","author":"Akhtar","year":"2008","journal-title":"Acta Pharma."},{"key":"10.1016\/j.tiv.2018.03.001_bb0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1755-148X.2010.00786.x","article-title":"Artificial skin in perspective: concepts and applications","volume":"24","author":"Brohem","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.tiv.2018.03.001_bb0020","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1755-148X.2012.00992.x","article-title":"Proteasome inhibition and ROS generation by 4-nerolidylcatechol induces melanoma cell death","volume":"25","author":"Brohem","year":"2012","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.tiv.2018.03.001_bb0025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1021\/jm00308a018","article-title":"Antimalarials. III. Benzothiazole amino alcohols","volume":"11","author":"Burger","year":"1968","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tiv.2018.03.001_bb0030","doi-asserted-by":"crossref","first-page":"611","DOI":"10.18388\/abp.2001_3895","article-title":"Detection of alkylation damage in human lymphocyte DNA with the comet assay","volume":"48","author":"Collins","year":"2001","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.tiv.2018.03.001_bb0035","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.2174\/1381612811319180009","article-title":"Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy","volume":"19","author":"Devine","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.tiv.2018.03.001_bb0040","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ejmech.2015.07.025","article-title":"Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives","volume":"101","author":"El-Damasy","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tiv.2018.03.001_bb0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejmech.2016.02.039","article-title":"Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-RafV600E and C-Raf kinase inhibitory activities","volume":"115","author":"El-Damasy","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tiv.2018.03.001_bb0050","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1476-5381.2011.01570.x","article-title":"Translational approaches targeting the p53 pathway for anti-cancer therapy","volume":"165","author":"Essmann","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tiv.2018.03.001_bb0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/157019312799079929","article-title":"Chemistry and biological activities of 1,3-benzothiazoles","volume":"9","author":"Facchinetti","year":"2012","journal-title":"Mini-Rev. Org. Chem."},{"key":"10.1016\/j.tiv.2018.03.001_bb0060","series-title":"Actas Dermo-Sifiliogr\u00e1ficas","first-page":"414","article-title":"Multiple primary melanoma","author":"Ferreres","year":"2009"},{"key":"10.1016\/j.tiv.2018.03.001_bb0065","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2174\/157018010792062740","article-title":"Synthesis and antitumor evaluation of (E)-2-benzothiazole hydrazones","volume":"7","author":"Francisco Nogueira","year":"2010","journal-title":"Lett. Drug Des. Discovery"},{"key":"10.1016\/j.tiv.2018.03.001_bb0070","series-title":"Culture of animal cells: a manual of basic technique and specialized applications","author":"Freshney","year":"2011"},{"key":"10.1016\/j.tiv.2018.03.001_bb0075","first-page":"163","article-title":"Human melanoma cell line UV responses show independency of p53 function","volume":"10","author":"Haapaj\u00e3rvi","year":"1999","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.tiv.2018.03.001_bb0080","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1755-148X.2010.00685.x","article-title":"PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells","volume":"23","author":"Halaban","year":"2010","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.tiv.2018.03.001_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-02489-3","article-title":"A benzothiazole derivative (5\u202fg) induces DNA damage and potent G2\/M arrest in cancer cells","volume":"7","author":"Hegde","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2018.03.001_bb0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1158\/2159-8290.CD-12-0408","article-title":"Genotype-selective combination therapies for melanoma identified by high-throughput drug screening","volume":"3","author":"Held","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tiv.2018.03.001_bb0095","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0960-894X(02)00930-7","article-title":"Antitumour benzothiazoles. Part 20: 3\u2032-cyano and 3\u2032-alkynyl-substituted 2-(4\u2032-aminophenyl)benzothiazoles as new potent and selective analogues","volume":"13","author":"Hutchinson","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tiv.2018.03.001_bb0100","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1101\/pdb.prot4493","article-title":"Acridine orange\/ethidium bromide (AO\/EB) staining to detect apoptosis","volume":"2006","author":"Kasibhatla","year":"2006","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.tiv.2018.03.001_bb0105","first-page":"2145","article-title":"Iodinated nitroimidazoles as radiosensitizers","volume":"25","author":"Krause","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tiv.2018.03.001_bb0110","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001222","article-title":"p53-based cancer therapy","volume":"2","author":"Lane","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.tiv.2018.03.001_bb0115","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2004.11.006","article-title":"Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome","volume":"119","author":"Lang","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.tiv.2018.03.001_bb0120","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1016\/j.bmcl.2009.04.124","article-title":"Identification of a disruptor of the MDM2-p53 protein-protein interaction facilitated by high-throughput in silico docking","volume":"19","author":"Lawrence","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tiv.2018.03.001_bb0125","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nprot.2007.30","article-title":"In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro","volume":"2","author":"Liang","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.tiv.2018.03.001_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejmech.2014.08.039","article-title":"Synthesis and anticancer activity of (E)-2-benzothiazole hydrazones","volume":"86","author":"Lindgren","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tiv.2018.03.001_bb0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1631\/jzus.B1400221","article-title":"Hypoxia-inducible factor 1 and breast cancer metastasis","volume":"16","author":"Liu","year":"2015","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.tiv.2018.03.001_bb0140","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1074\/jbc.272.8.5007","article-title":"Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties","volume":"272","author":"Lochter","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2018.03.001_bb0145","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejmech.2014.08.058","article-title":"Design, synthesis, and structure\u2013activity relationships of novel benzothiazole derivatives bearing the ortho-hydroxy N-carbamoylhydrazone moiety as potent antitumor agents","volume":"86","author":"Ma","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tiv.2018.03.001_bb0150","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/jnci\/djg123","article-title":"Determinants of BRAF mutations in primary melanomas","volume":"95","author":"Maldonado","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.tiv.2018.03.001_bb0155","doi-asserted-by":"crossref","first-page":"951574","DOI":"10.1155\/2012\/951574","article-title":"Role of p16(INK4A) in replicative senescence and DNA damage-induced premature senescence in p53-deficient human cells","volume":"2012","author":"Mirzayans","year":"2012","journal-title":"Biochem. Res. Int."},{"key":"10.1016\/j.tiv.2018.03.001_bb0160","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/cbdd.12879","article-title":"Synthesis and cytotoxic activity of certain benzothiazole derivatives against human MCF-7 cancer cell line","volume":"89","author":"Mohamed","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.tiv.2018.03.001_bb0165","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2009.11.026","article-title":"Mutant p53 drives invasion by promoting integrin recycling","volume":"139","author":"Muller","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.tiv.2018.03.001_bb0170","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1524\/zkri.2011.1424","article-title":"Crystal structures of hydrazones, 2-(1,3-benzothiazolyl)-NHNCHAr, prepared from arenealdehydes and 2-hydrazinyl-1,3-benzothiazole","volume":"226","author":"Nogueira","year":"2011","journal-title":"Z. Krist."},{"key":"10.1016\/j.tiv.2018.03.001_bb0175","series-title":"The Intersection Between DNA Damage Response and Cell Death Pathways","first-page":"243","volume":"34","author":"Nowsheen","year":"2012"},{"key":"10.1016\/j.tiv.2018.03.001_bb0180","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2004.11.004","article-title":"Mutant p53 gain of function in two mouse models of Li-fraumeni syndrome","volume":"119","author":"Olive","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.tiv.2018.03.001_bb0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1021\/jm00285a022","article-title":"Benzothiazolines as antituberculous agents","volume":"14","author":"Palmer","year":"1971","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tiv.2018.03.001_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00288","article-title":"Targeting oncogenic mutant p53 for cancer therapy","volume":"5","author":"Parrales","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tiv.2018.03.001_bb0195","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1590\/S0100-40422009000400032","article-title":"Aspectos mecan\u00edsticos da bioatividade e toxicidade de nitrocompostos","volume":"32","author":"Paulai","year":"2009","journal-title":"Quim Nova"},{"key":"10.1016\/j.tiv.2018.03.001_bb0200","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1021\/jm060318n","article-title":"Imino-tetrahydro-benzothiazole derivatives as p53 inhibitors: discovery of a highly potent in vivo inhibitor and its action mechanism","volume":"49","author":"Pietrancosta","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tiv.2018.03.001_bb0205","series-title":"Cytotoxic Drug Resistance Mechanisms","first-page":"17","article-title":"Cell sensitivity assays: clonogenic assay","author":"Plumb","year":"1999"},{"key":"10.1016\/j.tiv.2018.03.001_bb0210","series-title":"Synthesis and antidiabetic activity of 2-amino[5(4-sulphonylbenzylidine)-2,4-thiazolidinedione]-7-chloro-6-fluorobenzothiazole 44, 2404\u20132408","author":"Pujar","year":"2005"},{"key":"10.1016\/j.tiv.2018.03.001_bb0215","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1475-2867-11-36","article-title":"Effect of benzothiazole based conjugates in causing apoptosis by regulating p53, PTEN and MAP kinase proteins affecting miR-195a and miR-101-1","volume":"11","author":"Pushpavalli","year":"2011","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.tiv.2018.03.001_bb0220","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/onc.2016.198","article-title":"Metabolic rewiring in melanoma","volume":"36","author":"Ratnikov","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.tiv.2018.03.001_bb0225","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.2147\/OTT.S99807","article-title":"Next-generation sequencing: advances and applications in cancer diagnosis","volume":"9","author":"Serrat\u00ec","year":"2016","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.tiv.2018.03.001_bb0230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1615\/CritRevOncog.v18.i1-2.40","article-title":"On the origin of cancer metastasis","volume":"18","author":"Seyfried","year":"2013","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.tiv.2018.03.001_bb0235","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1158\/1078-0432.CCR-1169-3","article-title":"Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas","volume":"10","author":"Shinozaki","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tiv.2018.03.001_bb0240","first-page":"1005","article-title":"Synthesis and analgesic activity of some 2-[4-(alkyl thioureido) phenyl sulphonamido]-6-substituted benzothiazoles","volume":"16","author":"Siddiqui","year":"2004","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.tiv.2018.03.001_bb0245","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bmcl.2006.09.053","article-title":"Synthesis and anticonvulsant activity of sulfonamide derivatives-hydrophobic domain","volume":"17","author":"Siddiqui","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tiv.2018.03.001_bb0250","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","article-title":"A simple technique for quantitation of low levels of DNA damage in individual cells","volume":"175","author":"Singh","year":"1988","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.tiv.2018.03.001_bb0255","article-title":"Design, synthesis and mode of action of some benzothiazole derivatives bearing an amide moiety as antibacterial agents","volume":"4","author":"Singh","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.tiv.2018.03.001_bb0260","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ejca.2012.11.019","article-title":"Resistance to BRAF-targeted therapy in melanoma","volume":"49","author":"Sullivan","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tiv.2018.03.001_bb0265","first-page":"257","article-title":"Synthesis and anthelminitc activity of 3 (2-hydrazino benzothiazoles)-substituted indole-2-one","volume":"2","author":"Suresh","year":"2011","journal-title":"IJPR"},{"key":"10.1016\/j.tiv.2018.03.001_bb0270","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cell.2007.12.032","article-title":"Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7","volume":"132","author":"Wajapeyee","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.tiv.2018.03.001_bb0275","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1383-5718(02)00070-0","article-title":"A modified neutral comet assay: elimination of lysis at high temperature and validation of the assay with anti-single-stranded DNA antibody","volume":"518","author":"Wojew\u00f3dzka","year":"2002","journal-title":"Mutat. Res. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.tiv.2018.03.001_bb0280","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.canlet.2014.09.042","article-title":"SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2\/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo","volume":"355","author":"Xia","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tiv.2018.03.001_bb0285","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.3892\/ol.2016.5093","article-title":"Genetics and epigenetics of melanoma","author":"Zhang","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tiv.2018.03.001_bb0290","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1021\/ml400359z","article-title":"Discovery of potent and orally active p53-MDM2 inhibitors RO5353 and RO2468 for potential clinical development","volume":"5","author":"Zhang","year":"2014","journal-title":"ACS Med. Chem. Lett."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233318300675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233318300675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T18:59:48Z","timestamp":1603997988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233318300675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":58,"alternative-id":["S0887233318300675"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2018.03.001","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticancer potential of benzothiazolic derivative (E)-2-((2-(benzo[d]thiazol-2-yl)hydrazono)methyl)-4-nitrophenol against melanoma cells","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2018.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}